HYPOPHARYNX CANCER
Clinical trials for HYPOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for HYPOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo attack on tough head and neck cancers
Disease control CompletedThis study tested whether adding a new immunotherapy drug (pembrolizumab) to the standard treatment of chemotherapy plus radiation could be safe and more effective for people with locally advanced head and neck cancer. All 59 participants received the combined treatment. The main…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC